Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.
Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.

Find a Lilly Clinical Trial

4  Enrolling
12  Total Trials
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors (PIKASSO-01)
Enrolling
Conditions: Breast Cancer, Advanced Solid Tumors
Trial Name
PIKASSO-01
Drugs: LOXO-783
Age
≥18 years
Phase
I
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Enrolling
Conditions: Solid tumors
Drugs: LY4101174
Age
≥18 years
Phase
I
A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3
Enrolling
Conditions: Bladder Cancer, Advanced Solid Tumors
Drugs: LOX-24350 / LOXO-435, Pembrolizumab
Age
≥18 years
Phase
I
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Enrolling
Conditions: Lung Cancer, Advanced Solid Tumors
Drugs: LY3537982, Abemaciclib, Pembrolizumab, LY3295668, Cetuximab
Age
≥18 years
Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
8 
Completed Enrollment
12  Total Trials
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors...
Completed Enrollment
Conditions: Advanced Solid Tumors
Drugs: Abemaciclib, Irinotecan, Temozolomide, Dinutuximab and GM-CSF
Age
≤21 years
Phase
II
A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors (PACT)
Completed Enrollment
Conditions: Advanced Solid Tumor
Trial Name
PACT
Drugs: Ramucirumab, Abemaciclib, Merestinib, LY3300054
Age
≥18 years
Phase
I
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
Completed Enrollment
Conditions: Prostate Cancer
Drugs: Abemaciclib, Darolutamide, LHRH agonist/antagonist
Age
≥18 years
Phase
I
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer (CYCLONE 2)
Completed Enrollment
Conditions: Prostate Cancer
Trial Name
CYCLONE 2
Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Age
≥18 years
Phase
III
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to ...
Completed Enrollment
Conditions: Prostate Cancer
Trial Name
CYCLONE 3
Drugs: Abemaciclib, Abiraterone, LY2835219, Prednisone, Prednisolone
Age
≥18 years
Phase
III
A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment (JUVE-BASIS)
Completed Enrollment
Conditions: Lung Cancer, Thyroid Cancer and other Solid Tumors
Trial Name
JUVE-BASIS
Drugs: LOXO-260
Age
≥12 years
Phase
I
A Study of LY3200882 in Participants With Solid Tumors
Completed Enrollment
Conditions: Advanced Solid Tumor
Drugs: LY3200882
Age
≥18 years
Phase
I
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Completed Enrollment
Conditions: Advanced Solid Tumor
Drugs: LY3410738
Age
≥18 years
Phase
I